E. Lloret

1.0k citations
14 papers · 494 indexed · h-index 12

E. Lloret

13 papers receiving 477 citations

Peers

E. Lloret
Comparison fields: 5 of 53
  • Genetics 259
  • Pathology and Forensic Medicine 350
  • Oncology 151
  • Neurology 60
  • Gastroenterology 19
Replace C.S. Soman with:
C.S. Soman India
Françoise Delacrétaz Switzerland
Paolo Incardona Italy
Zhihong Hu United States
Anna Demurtas Italy
Camilla Vassallo Italy
Alex Freire Sandes Brazil
C Boccaccio France
M. Group United States
Frédéric Marrache France
E. Lloret relative to C.S. Soman India C.S. Soman's profile →
Citations per field
00.5×3.8×
C.S. Soman · 1×
Citations per year

Countries citing papers authored by E. Lloret

Since Specialization
Citations

This map shows the geographic impact of E. Lloret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lloret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lloret more than expected).

Fields of papers citing papers by E. Lloret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Lloret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lloret. The network helps show where E. Lloret may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E. Lloret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Lloret Line = papers co-authored together E. Lloret links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 200253
2 199915
3 199940
4 19990
5 199844
6 199825
7 199735
8 199714
9 199612
10 199532
11
Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
1995112
12 199587
13 199310
14
Immunocytochemical detection of dendritic cell by S-100 protein in the chicken.
199215

About E. Lloret

E. Lloret is a scholar working on Genetics, Pathology and Forensic Medicine and Gastroenterology, having authored 14 papers that have together received 494 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Genetic factors in colorectal cancer (4 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Genomics and Diagnostics (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Genetics (259 citations), Pathology and Forensic Medicine (350 citations) and Oncology (151 citations). E. Lloret has collaborated with scholars based in Spain, United Kingdom and France. Frequent co-authors include Miguel Á. Piris, Manuela Mollejo, P Algara, Javier Menárguez, Elı́as Campo, Eva Cristóbal, Juan F. Garcı́a, A.I. Sánchez, M. Sol Mateo and Margarita Sánchez‐Beato. Their work appears in journals such as Histopathology, The American Journal of Surgical Pathology, American Journal of Hematology, British Journal of Cancer and Chemical Senses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026